Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Merck
AstraZeneca
McKinsey
Johnson and Johnson
Baxter

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Norketamine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Norketamine?

Norketamine is an investigational drug.

There have been 8 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.

The most common disease conditions in clinical trials are Acute Pain, Pain, Postoperative, and Chronic Pain. The leading clinical trial sponsors are Tel-Aviv Sourasky Medical Center, University of Texas Southwestern Medical Center, and Columbia University.

There are twelve US patents protecting this investigational drug and forty-nine international patents.

Recent Clinical Trials for Norketamine
TitleSponsorPhase
The Role of HNKs in the Antidepressant Effect of KetamineColumbia UniversityPhase 1
Acute Pain Management in Patients on Opioid Replacement TherapyUniversity of California, San FranciscoPhase 1
Inhaled Nebulised S(+)-Ketamine for Postoperative AnalgesiaTampere University HospitalPhase 4

See all Norketamine clinical trials

Clinical Trial Summary for Norketamine

Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine

See all Norketamine clinical trials

US Patents for Norketamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Norketamine   Start Trial Ketamine derivatives Auckland Uniservices Limited (Auckland, NZ)   Start Trial
Norketamine   Start Trial Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Amorsa Therapeutics, Inc. (Littleton, MA)   Start Trial
Norketamine   Start Trial Assay for methoxetamine Randox Laboratories Ltd. (GB)   Start Trial
Norketamine   Start Trial Oral dosage forms of ketamine Develco Pharma Schweiz AG (Pratteln, CH)   Start Trial
Norketamine   Start Trial Ketamine analogues for treatment of thrombocytopenia Genentech, Inc. (South San Francisco, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Norketamine

Drugname Country Document Number Estimated Expiration Related US Patent
Norketamine Australia 2013328280 2032-10-08   Start Trial
Norketamine Brazil 112015007647 2032-10-08   Start Trial
Norketamine Canada 2922340 2032-10-08   Start Trial
Norketamine China 104837810 2032-10-08   Start Trial
Norketamine Eurasian Patent Organization 201590697 2032-10-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
Boehringer Ingelheim
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.